ISCV and CI [RSABE / ABEL]

posted by drgunasakaran1  – 2012-02-08 09:44 (4882 d 11:50 ago) – Posting: # 8070
Views: 21,750

Very very less chance to have that possibility.

You can widen the lower limit around 72.15% and upper limit to 138.59% if the ISCV% is around 45% for EMA submission in case of Replicate design.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
42 visitors (0 registered, 42 guests [including 7 identified bots]).
Forum time: 22:34 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5